In recent studies in BC patients, miRNA-342-5p has exhibited the highest expression in ER-positive and HER2+ luminal B tumors, showing a positive correlation between miR-342 expression and ERα expression [52]. This evidence concerns the gene ERBB2 and breast cancer.